Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.00    2.50 (5.88%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £86.34m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Board Appointment

16 Aug 2013 07:00

RNS Number : 8287L
Iofina PLC
16 August 2013
 



16 August 2013

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Board Appointment

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce the appointment of Mr Gary Dale Gatchell as an Executive Director to the Board. Gary will also serve as the Company's Finance Director with effect from September 3, 2013.

 

Gary (56) has a demonstrable twenty five year track record of financial experience and expertise. Most recently Gary was Chief Finance Officer of NASDAQ listed Ascent Solar Technologies, Inc. ("Ascent Solar").

 

Gary brings to Iofina a strong background in public company financial reporting and internal controls. He also has experience with private and public capital funding, as well as merger and acquisition activity on both the buy-side and sell-side.

 

From 2005 to 2008, he served as the Chief Financial Officer of Carrier Access Corporation ("Carrier Access"), a telecommunications equipment provider, to reorganise finance and administration infrastructure. Prior to joining Carrier Access, Gary was part of the original founding management team of Voyant Technologies, Inc. ("Voyant"), a leading provider of audio conferencing equipment that was subsequently acquired by Polycom, Inc. Serving as Chief Financial Officer he helped grow Voyant from eight employees to over two hundred, enabling a return of 20x to Voyant's Series A investors, after only four years. A previous audit manager at KPMG, Gary is a registered Certified Public Accountant and has a Master's degree in Accountancy from the University of Denver. 

The Company's current Finance Director, Michael Coddington, will remain with the Company as Chief Financial Officer of Iofina Chemical, Inc., allowing him to focus on the growth and financial aspects of this division. Michael has done an excellent job for the Company during his tenure as Finance Director. As was always planned, once the Company established itself as a key player in the iodine market, strengthening of the Company's financial team was envisioned to ensure rapid growth, good corporate governance and balance the workload across a sound financial management team of which Michael will be a key part.

Commenting on the appointment Dr. Chris Fay, Executive Chairman, said ''We are very pleased to welcome Gary to the Board at a very exciting time in the Company's development. Gary has extensive financial management experience that will be important as Finance Director in order to maximise this exciting rapid time of growth and profitability. The Board would like to thank Michael for his support to date and looks forward to working with him in the future"

 

Save as set out below there is no further information required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules:

 

Current Directorships:

Directorships in past 5 years

Colorado Advanced Manufacturing Alliance

 

 

 

For further information, please contact:

 

Dr. Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)20 3006 3135

www.iofina.com

 

Ben Colegrave/Chris Sim/James Rudd

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGMRKKRGFZM
Date   Source Headline
14th May 20197:00 amRNSStatement regarding share price rise
1st May 20197:00 amRNSFinal Results
17th Apr 20197:00 amRNSQ1 2019 Market Update
1st Apr 20197:00 amRNSCompletion of Debt Restructuring
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSDebt Restructuring
1st Feb 20194:40 pmRNSSecond Price Monitoring Extn
1st Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Jan 20197:00 amRNSChange of Registered Office
17th Jan 20197:00 amRNSMarket Update
20th Nov 20184:40 pmRNSSecond Price Monitoring Extn
20th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20187:00 amRNSDirector Appointment
18th Oct 20184:40 pmRNSSecond Price Monitoring Extn
18th Oct 20184:35 pmRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSQ3 2018 Update
20th Sep 20187:00 amRNSInterim Results
16th Jul 20187:00 amRNSH1 2018 Update
18th Jun 20187:00 amRNSMarket update
14th Jun 20187:00 amRNSGrant of Options
13th Jun 201811:30 amRNSResult of AGM
30th Apr 20187:00 amRNSFinal Results and Notice of AGM
18th Apr 20187:00 amRNSQ1 2018 Market Update
16th Apr 20181:30 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
20th Mar 20183:05 pmRNSHolding(s) in Company
15th Mar 20181:24 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSProduction commences at IO#7
30th Jan 20183:00 pmRNSHolding(s) in Company
15th Jan 20187:00 amRNSMarket Update
14th Dec 20177:00 amRNSMarket Update
16th Nov 20177:00 amRNSIO#7 Progress and Market Update
20th Oct 20174:40 pmRNSSecond Price Monitoring Extn
20th Oct 20174:35 pmRNSPrice Monitoring Extension
10th Oct 20177:00 amRNSQ3 2017 Market Update
22nd Sep 20177:00 amRNSInterim Results
12th Sep 20177:00 amRNSConstruction of IO#7 to Expand Iodine Production
14th Jul 20177:00 amRNSCorporate and Production Update
14th Jun 201712:15 pmRNSResult of AGM
13th Jun 201712:07 pmRNSSecond Price Monitoring Extn
13th Jun 201712:02 pmRNSPrice Monitoring Extension
8th Jun 201712:07 pmRNSSecond Price Monitoring Extn
8th Jun 201712:02 pmRNSPrice Monitoring Extension
7th Jun 201712:07 pmRNSSecond Price Monitoring Extn
7th Jun 201712:02 pmRNSPrice Monitoring Extension
6th Jun 201712:07 pmRNSSecond Price Monitoring Extn
6th Jun 201712:02 pmRNSPrice Monitoring Extension
24th May 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.